{"id":"https://openalex.org/W2056198101","doi":"https://doi.org/10.1212/wnl.45.3_suppl_3.s6","title":"The rationale for the use of dopamine agonists in Parkinson's disease","display_name":"The rationale for the use of dopamine agonists in Parkinson's disease","alternate_titles":[],"publication_year":1995,"publication_date":"1995-03-01","ids":{"openalex":"https://openalex.org/W2056198101","doi":"https://doi.org/10.1212/wnl.45.3_suppl_3.s6","mag":"2056198101","pmid":"https://pubmed.ncbi.nlm.nih.gov/7715795"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.45.3_suppl_3.s6","doi":"https://doi.org/10.1212/wnl.45.3_suppl_3.s6","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.45.3_suppl_3.s6","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2056198101"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105511214","display_name":"Peter G. Jenner","orcid":"https://orcid.org/0009-0006-0327-7584","observed_orcids":["https://orcid.org/0009-0006-0327-7584"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter Jenner","raw_affiliation_strings":["Address correspondence and reprint requests to Prof. Peter Jenner, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London, SW3 6LX, UK","From the Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Address correspondence and reprint requests to Prof. Peter Jenner, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London, SW3 6LX, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"From the Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London, England","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105511214"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":null,"apc_paid":null,"fwci":2.9497,"has_fulltext":false,"cited_by_count":156,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92929293,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"45","issue":"3_suppl_3","first_page":"S6","last_page":"S12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.8769999742507935},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.6949999928474426},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-d3-receptor","display_name":"dopamine D3 receptor","score":0.8730000257492065},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.9459999799728394},{"id":"https://openalex.org/keywords/mptp","display_name":"MPTP","score":0.8790000081062317},{"id":"https://openalex.org/keywords/caudate-putamen","display_name":"caudate-putamen","score":0.9169999957084656},{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.8650000095367432},{"id":"https://openalex.org/keywords/enkephalin","display_name":"enkephalin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tachykinins","display_name":"tachykinins","score":0.9409999847412109},{"id":"https://openalex.org/keywords/nigrostriatal-pathway","display_name":"nigrostriatal pathway","score":0.890999972820282},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.8899999856948853},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9390000104904175}],"concepts":[{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.7457679510116577},{"id":"https://openalex.org/C2779714222","wikidata":"https://www.wikidata.org/wiki/Q550934","display_name":"Putamen","level":2,"score":0.6882057189941406},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.6546323299407959},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.6182538866996765},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.617953360080719},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6089361310005188},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.5639692544937134},{"id":"https://openalex.org/C2778187257","wikidata":"https://www.wikidata.org/wiki/Q464210","display_name":"Basal ganglia","level":3,"score":0.5471575856208801},{"id":"https://openalex.org/C2781423529","wikidata":"https://www.wikidata.org/wiki/Q1132309","display_name":"Caudate nucleus","level":2,"score":0.5367473363876343},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.48723044991493225},{"id":"https://openalex.org/C120750228","wikidata":"https://www.wikidata.org/wiki/Q2035393","display_name":"Dopamine receptor D1","level":4,"score":0.4513477683067322},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.44759565591812134},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.44403451681137085},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.4412260055541992},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.43754512071609497},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4258931875228882},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41344085335731506},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38031700253486633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36385437846183777},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3207513093948364},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30000847578048706},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.2100156545639038},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.14429232478141785},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.14055472612380981},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.08085379004478455}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1212/wnl.45.3_suppl_3.s6","doi":"https://doi.org/10.1212/wnl.45.3_suppl_3.s6","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.45.3_suppl_3.s6","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:7715795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7715795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1511607","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1511607/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurology , 45 (3 Suppl ) S6-12. (1995)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306430","display_name":"National Parkinson Foundation","ror":"https://ror.org/005aa3k38"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W134606390","https://openalex.org/W1480429336","https://openalex.org/W1966092598","https://openalex.org/W1970102973","https://openalex.org/W1973890100","https://openalex.org/W1976856793","https://openalex.org/W1977817124","https://openalex.org/W1978598997","https://openalex.org/W1986090218","https://openalex.org/W1987193373","https://openalex.org/W2013826930","https://openalex.org/W2024464966","https://openalex.org/W2026114626","https://openalex.org/W2028578047","https://openalex.org/W2034811328","https://openalex.org/W2037695648","https://openalex.org/W2042809317","https://openalex.org/W2043481087","https://openalex.org/W2046064727","https://openalex.org/W2047028663","https://openalex.org/W2047819781","https://openalex.org/W2058239548","https://openalex.org/W2061359205","https://openalex.org/W2067901223","https://openalex.org/W2068781960","https://openalex.org/W2069312167","https://openalex.org/W2070238106","https://openalex.org/W2070773696","https://openalex.org/W2071464015","https://openalex.org/W2073958803","https://openalex.org/W2075004169","https://openalex.org/W2075577390","https://openalex.org/W2081963528","https://openalex.org/W2092683148","https://openalex.org/W2092937952","https://openalex.org/W2096386031","https://openalex.org/W2104227218","https://openalex.org/W2144684127","https://openalex.org/W2157443081","https://openalex.org/W2163131045","https://openalex.org/W2265069953","https://openalex.org/W2273119576","https://openalex.org/W2280099853","https://openalex.org/W2285760952","https://openalex.org/W2316080658","https://openalex.org/W2325211721","https://openalex.org/W2399943773","https://openalex.org/W4247588575","https://openalex.org/W4253387038"],"related_works":["https://openalex.org/W2112692826","https://openalex.org/W2026914327","https://openalex.org/W1995566504","https://openalex.org/W140972958","https://openalex.org/W2321718618","https://openalex.org/W2280099853","https://openalex.org/W2069463443","https://openalex.org/W168655087","https://openalex.org/W2145093200","https://openalex.org/W126943151"],"abstract_inverted_index":{"Experimental":[0],"and":[1,9,22,28,73,82,101,130,141,201],"clinical":[2],"studies":[3],"indicate":[4],"that":[5,185],"both":[6,26],"dopamine":[7,206],"D2-like":[8],"D1-like":[10],"receptors":[11,30],"are":[12],"important":[13],"in":[14,34,53,65,78,85,90,112,120,127,167],"reversing":[15],"the":[16,39,47,55,69,108,128,136,146,150,157,165,196,199,230],"motor":[17,227],"symptoms":[18],"of":[19,25,41,60,110,118,145,233],"Parkinson's":[20,121],"disease,":[21],"therefore":[23],"stimulation":[24],"D1":[27,72,88],"D2":[29,74],"may":[31],"be":[32,59],"advantageous":[33],"its":[35],"treatment.":[36],"At":[37],"present,":[38],"role":[40],"other":[42],"receptor":[43,57],"subtypes,":[44],"such":[45],"as":[46],"D3":[48,56],"receptor,":[49],"remains":[50],"unknown,":[51],"although":[52],"primates":[54,81],"might":[58,94,123,219,242],"importance":[61],"because":[62],"it":[63],"exists":[64],"significant":[66],"amounts":[67],"within":[68],"caudate-putamen.":[70],"Both":[71],"agonists":[75,89,207],"induce":[76],"dyskinesias":[77,84,111,119],"drug-naive,":[79],"MPTP-treated":[80,114],"provoke":[83,236],"levodopa-primed":[86],"animals.":[87],"low":[91],"doses,":[92],"however,":[93],"have":[95],"antiparkinsonian":[96],"effects":[97],"without":[98],"inducing":[99],"dyskinesias,":[100],"on":[102,179],"repeated":[103],"administration":[104],"perhaps":[105],"can":[106],"diminish":[107],"intensity":[109],"levodopa-primed,":[113],"primates.":[115],"The":[116],"production":[117],"disease":[122],"reflect":[124,220],"an":[125],"imbalance":[126,192],"D1-direct":[129],"D2-indirect":[131],"GABAergic":[132],"output":[133,194],"pathways":[134],"from":[135,195],"caudate-putamen,":[137],"which":[138],"colocalize":[139],"tachykinins":[140],"enkephalins,":[142],"respectively.":[143],"Destruction":[144],"nigrostriatal":[147],"pathway":[148],"decreases":[149],"mRNA":[151,158,170,180],"for":[152,159,181],"substance":[153,168],"P":[154,169],"but":[155,171],"elevates":[156],"enkephalin.":[160,182],"Treatment":[161],"with":[162],"levodopa":[163,186,212,234],"reverses":[164],"decrease":[166],"has":[172],"either":[173],"a":[174,190],"partial":[175],"or":[176,229],"no":[177],"effect":[178],"This":[183,218],"suggests":[184],"treatment":[187],"leads":[188],"to":[189,213,224,235],"new":[191],"between":[193],"striatum":[197],"through":[198],"direct":[200],"indirect":[202],"pathways.":[203],"In":[204],"contrast,":[205],"appear":[208],"less":[209],"able":[210],"than":[211],"manipulate":[214],"basal":[215],"ganglia":[216],"outflow.":[217],"their":[221],"decreased":[222],"ability":[223,232],"reverse":[225],"parkinsonian":[226],"deficits":[228],"greater":[231],"dyskinesias.":[237],"Dopamine":[238],"agonist":[239],"drugs":[240],"also":[241],"exert":[243],"neuroprotective":[244],"actions.(ABSTRACT":[245],"TRUNCATED":[246],"AT":[247],"250":[248],"WORDS)":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2056198101","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
